Global Cancer Biomarkers Market 2012-2016

Global Cancer Biomarkers Market 2012-2016


January 11, 2013
37 Pages - SKU: INF4944581
License type:
Online Download      US $2,000.00
Five User License      US $2,300.00
Global Site License      US $3,000.00
Countries covered: Global

TechNavio's analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market.

TechNavio's report, the Global Cancer Biomarkers market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Biomarkers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies Inc., Gen-Probe Inc., Hologic, Inc., and Roche Diagnostics Corp.The other vendors mentioned in the report are Agendia BV, Ambrilia Biopharma, Astellas Pharma US Inc., Morphotek, Inc., Gen-Probe, Inc., Veridex LLC, Morphotek, Inc., Immunomedics, Inc., Clarient, Inc.

Key questions answered in this report:
  • What will the market size be in 2016 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.



More Oncology/Hematology reports by Infiniti Research Limited - TechNavio

Global Testicular Cancer Drugs Market 2014-2018 by Infiniti Research Limited - TechNavio
Global Testicular Cancer Drugs Market 2014-2018TechNavio's analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4.02 percent over the period ...
Global Gynecological Cancers Market 2014-2018 by Infiniti Research Limited - TechNavio
Global Gynecological Cancers Market 2014-2018TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One ...
Global Vena Cava Filters Market 2012-2016 by Infiniti Research Limited - TechNavio
Global Vena Cava Filters Market 2012-2016TechNavio's analysts forecast the Global Vena Cava Filters market to grow at a CAGR of 11.37 percent over the period ...
Global Ablation Technologies Market 2012-2016 by Infiniti Research Limited - TechNavio
TechNavio's analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors ...
See all reports like this >>

More Global Oncology/Hematology reports

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide by Renub Research
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Cervical Cancer Test Market Overview Cervical ...
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 by GlobalData
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data ...
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 by GlobalData
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 provides data on the Neuroendocrine Cancer ...
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 by GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the ...
See all reports like this >>